Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134108) titled 'Efficacy and safety of ivarmacitinib combined with narrow-band UVB phototherapy for treatment of vitiligo: A prospective, randomized, double-blind, vehicle-controlled trial' on Oct. 10.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Air Force Military Medical University
Condition:
Vitiligo
Intervention:
Experimental group:Ivarmacitinib Sulfate tablets and NB-UVB phototherapy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-01
Target Sample Size: Experimental group:98;Control group:98;
Countries of Recruitmen...